ReviewLife (Basel, Switzerland)2025
Significance of Whole Blood Viscosity in Acute Ischemic Stroke.
Review in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Shear-Dependent Agreement and Clinical Reclassification of Whole-Blood Viscosity Measurements: A Paired Comparison of Rheovis 2000A and Hemovister.Diagnostics (Basel, Switzerland) · 2026Article
- Microcirculatory failure after successful recanalization in ischemic stroke: insights into mechanisms, imaging, and therapeutic strategies.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The paper provides a comprehensive review of the relationship between whole blood viscosity (WBV) and acute ischemic stroke (AIS) concerning AIS risk and type, and its treatment and prognosis. A significant increase in diastolic blood viscosity (DBV) at the onset of AIS was established in the small-artery occlusion stroke subtype. In patients with atherothrombotic causes of AIS, systolic (SBV) and DBV values were higher than in those with an embolic cause. The higher WBV at low shear rates on hospital admission is associated with an increased risk of early neurological deterioration and disease progression in the patients with AIS. Most studies reveal the association of increased WBV at the stroke onset with poor functional outcome after applying intravenous thrombolysis or endovascular thrombectomy. However, significant reduction in WBV after the combined use of these therapeutic methods in AIS patients was observed. Whole blood viscosity has an obvious effect on the risk of AIS, its clinical severity and outcome. Further research is needed due to the multiple devices and techniques used, like cone-plate viscometers, scanning capillary viscometers, EMS viscometers, parallel-plate rheometers and the different associations of WBV with some of the applied treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.